These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 32046674

  • 1. Molecular mechanism of azoles resistant Candida albicans in a patient with chronic mucocutaneous candidiasis.
    Zhang MR, Zhao F, Wang S, Lv S, Mou Y, Yao CL, Zhou Y, Li FQ.
    BMC Infect Dis; 2020 Feb 11; 20(1):126. PubMed ID: 32046674
    [Abstract] [Full Text] [Related]

  • 2. Selected mechanisms of molecular resistance of Candida albicans to azole drugs.
    Gołąbek K, Strzelczyk JK, Owczarek A, Cuber P, Ślemp-Migiel A, Wiczkowski A.
    Acta Biochim Pol; 2015 Feb 11; 62(2):247-51. PubMed ID: 25901298
    [Abstract] [Full Text] [Related]

  • 3. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
    Sanglard D, Coste AT.
    Antimicrob Agents Chemother; 2016 Jan 11; 60(1):229-38. PubMed ID: 26482310
    [Abstract] [Full Text] [Related]

  • 4. Assessment of antifungal resistance and associated molecular mechanism in Candida albicans isolates from different cohorts of patients in North Indian state of Haryana.
    Kumar A, Nair R, Kumar M, Banerjee A, Chakrabarti A, Rudramurthy SM, Bagga R, Gaur NA, Mondal AK, Prasad R.
    Folia Microbiol (Praha); 2020 Aug 11; 65(4):747-754. PubMed ID: 32219719
    [Abstract] [Full Text] [Related]

  • 5. Reduced susceptibility of Candida albicans clinical isolates to azoles and detection of mutations in the ERG11 gene.
    Zhang L, Yang HF, Liu YY, Xu XH, Ye Y, Li JB.
    Diagn Microbiol Infect Dis; 2013 Dec 11; 77(4):327-9. PubMed ID: 24070847
    [Abstract] [Full Text] [Related]

  • 6. The TAC1 Gene in Candida albicans: Structure, Function, and Role in Azole Resistance: A Mini-Review.
    Mahdizade AH, Hoseinnejad A, Ghazanfari M, Boozhmehrani MJ, Bahreiny SS, Abastabar M, Galbo R, Giuffrè L, Haghani I, Romeo O.
    Microb Drug Resist; 2024 Jul 11; 30(7):288-296. PubMed ID: 38770776
    [Abstract] [Full Text] [Related]

  • 7. Molecular mechanisms associated with Fluconazole resistance in clinical Candida albicans isolates from India.
    Mane A, Vidhate P, Kusro C, Waman V, Saxena V, Kulkarni-Kale U, Risbud A.
    Mycoses; 2016 Feb 11; 59(2):93-100. PubMed ID: 26648048
    [Abstract] [Full Text] [Related]

  • 8. FLO8 deletion leads to azole resistance by upregulating CDR1 and CDR2 in Candida albicans.
    Li WJ, Liu JY, Shi C, Zhao Y, Meng LN, Wu F, Xiang MJ.
    Res Microbiol; 2019 Feb 11; 170(6-7):272-279. PubMed ID: 31449848
    [Abstract] [Full Text] [Related]

  • 9. Genetic dissection of azole resistance mechanisms in Candida albicans and their validation in a mouse model of disseminated infection.
    MacCallum DM, Coste A, Ischer F, Jacobsen MD, Odds FC, Sanglard D.
    Antimicrob Agents Chemother; 2010 Apr 11; 54(4):1476-83. PubMed ID: 20086148
    [Abstract] [Full Text] [Related]

  • 10. Azole resistance in Candida albicans from animals: Highlights on efflux pump activity and gene overexpression.
    Rocha MFG, Bandeira SP, de Alencar LP, Melo LM, Sales JA, Paiva MAN, Teixeira CEC, Castelo-Branco DSCM, Pereira-Neto WA, Cordeiro RA, Sidrim JJC, Brilhante RSN.
    Mycoses; 2017 Jul 11; 60(7):462-468. PubMed ID: 28295690
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Ibuprofen reverts antifungal resistance on Candida albicans showing overexpression of CDR genes.
    Ricardo E, Costa-de-Oliveira S, Dias AS, Guerra J, Rodrigues AG, Pina-Vaz C.
    FEMS Yeast Res; 2009 Jun 11; 9(4):618-25. PubMed ID: 19416368
    [Abstract] [Full Text] [Related]

  • 13. Clonal spread and azole-resistant mechanisms of non-susceptible Candida albicans isolates from vulvovaginal candidiasis patients in three Shanghai maternity hospitals.
    Wu Y, Li C, Wang Z, Gao J, Tang Z, Chen H, Ying C.
    Med Mycol; 2018 Aug 01; 56(6):687-694. PubMed ID: 29136186
    [Abstract] [Full Text] [Related]

  • 14. Antifungal effect of Echinophora platyloba on expression of CDR1 and CDR2 genes in fluconazole-resistant Candida albicans.
    Khajeh E, Hosseini Shokouh SJ, Rajabibazl M, Roudbary M, Rafiei S, Aslani P, Farahnejad Z.
    Br J Biomed Sci; 2016 Aug 01; 73(1):44-8. PubMed ID: 27182677
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Genotypic evolution of azole resistance mechanisms in sequential Candida albicans isolates.
    Coste A, Selmecki A, Forche A, Diogo D, Bougnoux ME, d'Enfert C, Berman J, Sanglard D.
    Eukaryot Cell; 2007 Oct 01; 6(10):1889-904. PubMed ID: 17693596
    [Abstract] [Full Text] [Related]

  • 18. Overexpression and mutation as a genetic mechanism of fluconazole resistance in Candida albicans isolated from human immunodeficiency virus patients in Indonesia.
    Rosana Y, Yasmon A, Lestari DC.
    J Med Microbiol; 2015 Sep 01; 64(9):1046-1052. PubMed ID: 26297039
    [Abstract] [Full Text] [Related]

  • 19. Missense mutation in CgPDR1 regulator associated with azole-resistant Candida glabrata recovered from Thai oral candidiasis patients.
    Tantivitayakul P, Lapirattanakul J, Kaypetch R, Muadcheingka T.
    J Glob Antimicrob Resist; 2019 Jun 01; 17():221-226. PubMed ID: 30658200
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.